Pharma drags London stocks lower after Trump's tariff blitz
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 01 2025
0mins
Source: Reuters
Market Reaction to U.S. Tariffs: British equities fell, with the FTSE 100 down 0.7% and the FTSE 250 nearly 1%, as investors reacted to President Trump's new tariffs on multiple countries and his demands for lower prescription drug prices, significantly impacting healthcare stocks.
Sector Performance and Economic Indicators: The Industrial Support Services sector declined after Intertek Group reported disappointing revenue growth, while some companies like Melrose Industries and Pearson saw gains. Additionally, British house prices rose slightly faster than expected in July, and the EU plans to remove tariffs on key steel products from the UK.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
